We are live on ! Find out more
REVB icon

Revelation Biosciences
REVB

4 hedge funds and large institutions have $95.8K invested in Revelation Biosciences in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

359% more capital invested

Capital invested by funds: $20.9K → $95.8K (+$74.9K)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

33% more funds holding

Funds holding: 3 → 4 (+1)

0.01% more ownership

Funds ownership: 0% → 0.02% (+0.01%)

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$49.5K
2
HF
HRT Financial
New York
+$36.3K
3
TRCT
Tower Research Capital (TRC)
New York
+$4.13K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$2.48K

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$822
2
Wells Fargo
Wells Fargo
California
-$8

REVB Hedge Fund Activity: Q2 2024 in Review

4 institutional investors reported a position in Revelation Biosciences (REVB) for Q2 2024, worth a combined $95.8K — up 359% from $20.9K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new REVB positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $49.5K. The largest seller was Osaic Holdings, exiting entirely with an estimated $822 sold.

  • 4 institutional investors held Revelation Biosciences (REVB) as of Q2 2024, up from 3 in Q1 2024.
  • Funds reported $95.8K of Revelation Biosciences stock for Q2 2024, up 359% quarter-over-quarter.
  • 2 funds opened new Revelation Biosciences positions in Q2 2024 and 1 closed out, a net change of +1 holder.
  • The largest Revelation Biosciences buyer in Q2 2024 was UBS Group, an estimated $49.5K added.
  • The largest Revelation Biosciences seller in Q2 2024 was Osaic Holdings, an estimated $822 sold.

Based on aggregated 13F filings for Q2 2024.